PortfoliosLab logo
Ultralife Corporation (ULBI)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US9038991025

CUSIP

903899102

IPO Date

Dec 23, 1992

Highlights

Market Cap

$113.10M

EPS (TTM)

$0.34

PE Ratio

20.00

Total Revenue (TTM)

$173.28M

Gross Profit (TTM)

$43.59M

EBITDA (TTM)

$9.85M

Year Range

$4.07 - $12.40

Target Price

$14.00

Short %

2.81%

Short Ratio

3.41

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Ultralife Corporation

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Ultralife Corporation (ULBI) returned -10.60% year-to-date (YTD) and -43.84% over the past 12 months. Over the past 10 years, ULBI returned 5.15% annually, underperforming the S&P 500 benchmark at 10.84%.


ULBI

YTD

-10.60%

1M

42.31%

6M

-12.48%

1Y

-43.84%

3Y*

10.25%

5Y*

-4.42%

10Y*

5.15%

^GSPC (Benchmark)

YTD

0.52%

1M

6.32%

6M

-1.44%

1Y

12.25%

3Y*

12.45%

5Y*

14.20%

10Y*

10.84%

*Annualized

Monthly Returns

The table below presents the monthly returns of ULBI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20251.74%-17.28%-14.19%-16.73%48.66%-10.60%
20243.67%27.86%-2.54%32.80%-0.51%-8.76%12.81%-12.69%-13.58%-6.97%-8.80%-2.87%9.24%
20235.44%-0.74%-0.50%4.48%0.24%14.96%69.21%15.63%3.06%-23.98%0.94%-8.95%76.68%
2022-11.42%0.37%0.00%-8.01%-2.23%-5.80%-1.54%11.61%-3.80%2.91%-15.56%-7.66%-36.09%
2021-9.27%16.01%21.59%-4.59%15.57%-8.21%-5.25%3.15%-13.06%-12.08%-14.54%12.90%-6.65%
2020-5.95%1.87%-26.55%35.58%18.44%-16.05%1.28%-10.99%-6.65%-12.54%30.81%-4.15%-12.45%
201918.52%32.88%-3.39%12.46%-32.90%2.58%9.81%-1.83%1.05%-0.23%-1.97%-12.75%9.48%
20183.82%18.38%24.22%-15.50%23.08%-7.69%4.69%-13.93%-5.78%-16.93%8.42%-8.04%3.05%
201711.11%-0.91%-0.00%0.92%16.36%12.50%-4.51%-5.45%3.85%11.11%-12.67%0.00%32.32%
2016-12.85%-11.01%2.20%-6.84%-13.63%21.60%-13.17%-1.15%-4.42%-0.24%23.17%-1.98%-23.37%
20157.03%5.97%10.91%5.78%-0.84%1.46%-2.86%6.63%35.71%15.11%1.77%-6.38%106.39%
201417.18%-9.13%12.43%-15.29%9.44%-2.54%-8.33%-3.44%-4.68%-2.16%-8.83%8.30%-11.83%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ULBI is 15, meaning it’s performing worse than 85% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ULBI is 1515
Overall Rank
The Sharpe Ratio Rank of ULBI is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of ULBI is 1111
Sortino Ratio Rank
The Omega Ratio Rank of ULBI is 1414
Omega Ratio Rank
The Calmar Ratio Rank of ULBI is 1919
Calmar Ratio Rank
The Martin Ratio Rank of ULBI is 2121
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Ultralife Corporation (ULBI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Ultralife Corporation Sharpe ratios as of May 30, 2025 (values are recalculated daily):

  • 1-Year: -0.83
  • 5-Year: -0.07
  • 10-Year: 0.10
  • All Time: -0.03

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Ultralife Corporation compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History


Ultralife Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Ultralife Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ultralife Corporation was 92.90%, occurring on Oct 18, 2002. The portfolio has not yet recovered.

The current Ultralife Corporation drawdown is 72.82%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.9%Oct 2, 19951767Oct 18, 2002
-54.46%Jan 22, 199380May 17, 1993255May 20, 1994335
-41.76%Nov 22, 199452Feb 6, 1995157Sep 20, 1995209
-20%Jun 7, 199411Jun 21, 199474Oct 5, 199485
-13.85%May 27, 19942May 31, 19944Jun 6, 19946
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ultralife Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Ultralife Corporation, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -92.3%.


-0.100.000.100.200.3020212022202320242025
0.01
0.15
Actual
Estimate

Valuation

The Valuation section provides an overview of how Ultralife Corporation is priced in the market compared to other companies in the Electrical Equipment & Parts industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ULBI, comparing it with other companies in the Electrical Equipment & Parts industry. Currently, ULBI has a P/E ratio of 20.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ULBI compared to other companies in the Electrical Equipment & Parts industry. ULBI currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ULBI relative to other companies in the Electrical Equipment & Parts industry. Currently, ULBI has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ULBI in comparison with other companies in the Electrical Equipment & Parts industry. Currently, ULBI has a P/B value of 0.8. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items